Dr. Jawad Alzeer is a senior scientist who has completed a PhD in organic chemistry and has worked as a postdoctoral researcher and research associate in various institutions. He has been involved in the discovery of a new HIV inhibitor and has focused on targeted gene therapy and the design of G-quadruplex ligands for cancer therapy. Currently, he is the director of the Swiss Scientific Society for the Developing Countries and a senior researcher at the University of Zurich, where he focuses on linking medicine and chemistry and developing new medical concepts related to prevention and complete recovery.
Title : Buffers and homeostasis: A key to maintaining health
Title : Reduction of viral resistance and activation of the immune system through implementation of the LeChatelier principle